New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based analysis and image classification using machine learning models may be promising in accurately predicting Alzheimer’s disease risk.

Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning, also known as artificial intelligence (AI), to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to both companies.

September 17, 2018 — At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago ...

Solis Mammography declared September Breast Wellness Month and encouraging every woman to #DitchTheSquish with the ...

Fujifilm Medical Systems U.S.A., Inc. is continuing its partnership with the American College of Radiology (ACR) ...

Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age ...

Columbus Regional Health (Columbus, Ind.) has deployed a Carestream DRX-Transportable System/Lite to complete its ...

Siemens Healthineers announced the first global installation of its newest ultrasound system, the Acuson Sequoia, at ...

UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best ...

Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has ...